Which age group typically receives the DTaP vaccine?

The DTaP vaccine is specifically designed for infants and young children, typically administered in a series starting at 2 months of age and continuing through 6 years old. This vaccine protects against three serious diseases: diphtheria, tetanus, and pertussis (whooping cough). The series is crucial as it helps build a child's immunity during their early years when they are most vulnerable to these infections.

The other options refer to different populations that do not receive the DTaP vaccine as a routine part of their immunization schedule. Adults over 65 generally receive the Td or Tdap vaccines for tetanus and diphtheria instead. Teenagers usually receive the Tdap booster, which provides continued protection against these diseases but is not the primary series. Pregnant women are recommended to receive the Tdap vaccine during each pregnancy to help protect newborns, but this is not the same as the DTaP, which is specifically for young children.